305 related articles for article (PubMed ID: 33631554)
1. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
3. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
4. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
5. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
[TBL] [Abstract][Full Text] [Related]
6. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
8. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
9. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
[TBL] [Abstract][Full Text] [Related]
10. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
11. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
Bugybayeva D; Kydyrbayev Z; Zinina N; Assanzhanova N; Yespembetov B; Kozhamkulov Y; Zakarya K; Ryskeldinova S; Tabynov K
Infect Dis Poverty; 2021 Feb; 10(1):13. PubMed ID: 33593447
[TBL] [Abstract][Full Text] [Related]
12. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
13. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
Wang Z; Niu J; Wang S; Lv Y; Wu Q
Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
Kahl-McDonagh MM; Ficht TA
Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
[TBL] [Abstract][Full Text] [Related]
16. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
17. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
20. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
